Vaccines: the road ahead

The UK approved the first COVID-19 vaccine in early December, and the pandemic entered a new phase. While this is certainly a moment for optimism, vaccines bring new challenges around efficacy, distribution and public resistance. This week’s panel includes Caroline Naumann, Associate Director for Crisis and Security Consulting and also our COVID-19 Advisory Lead in EMEA,  and Joseph Smith, Senior Analyst responsible for providing analysis on international business issues as well as one of our leaders on analysis of the vaccine rollout.

Om Podcasten

Listen in as experts in risk discuss how organisations can navigate a world of ever-changing risk and connectivity. From major geopolitical shifts to on-the-ground operational challenges, The Global Insight is here with in-depth analysis, perspective and guidance.